William Y. Kim
@WilliamKimMD
Followers
2K
Following
2K
Media
68
Statuses
584
Prof of Med, Gen, Pharm UNC Chapel Hill. Physician-scientist, @wesleyan_u @BrownMedicine @BIDMC_IM @DanaFarber Alum. Working to cure #bladdercancer & #RCC.
Chapel Hill, NC
Joined October 2013
1/ Pls✅out our work w/ a completely unexpected finding demonstrating that FGFR inhibition suppresses Treg proliferation in a cell autonomous manner in context of FGFR3 driven #bladdercancer 👇👇👇 https://t.co/Xjp60MrFqq
https://t.co/tRZCTAORK5 Cover art credit: Riley S. Kim
13
28
96
Congrats @UroDocAsh on your leadership of this truly global society @IBCG_BladderCA bringing the best minds from multidisciplinary teams and patients together to advance science and disseminate knowledge about bladder cancer. Honored to serve on the board and be a part of the
On behalf of the IBCG Board, thank you to all who joined us from across the globe for #IBCG25 Your expertise, energy, and commitment made this a true success. It was a joy to see familiar faces and new ones alike, and to share in the lively debates and genuine camaraderie that
3
9
39
Last session the ‘Good News’ with @charlesryanmd & @CaPsurvivorship @GoodNews_Cancer ‘We have hope and a bright future’ 🥰 #WorldGU25
0
9
34
This is HUGE! No embargo needed for @AACR publications deposited in PubMed Central - enabling compliance with the NIH public access policy without spending exorbitant open access fees.
You can read the AACR journals' policy here: https://t.co/mq2WsdK9Pd "The Author Accepted Manuscript is permitted to be deposited in PMC and made available to the public on or after the first online publication date of the Version of Record."
1
16
78
IMVIGOR011: Atezo vs placebo in ctDNA+ve bladder ca (including -ve becoming +ve) post cystectomy hit OS/PFS. It also tracks outcomes in the ctDNA-ve, supporting a ctDNA adjusted approach. It’s been a long journey for atezo in UC but it has +ve OS at last https://t.co/dPqlvr2rnV
9
114
286
All that you can’t leave behind on MIBC is online @JCO_ASCO @ASCO @MattGalsky @UroDocAsh @l_ballas Muscle-Invasive Bladder Cancer: A Watershed Moment | Journal of Clinical Oncology
ascopubs.org
The treatment of muscle-invasive bladder cancer (MIBC) has evolved substantially over the past several decades. Muscle-invasive bladder cancer is a disease of older individuals who often have...
3
20
51
What is the impact of sex on outcomes in NMIBC? Check out our latest study in @EurUrolOncol led by @niyatilobo @MDAndersonNews #OncSurgery 🧵/1 https://t.co/Wc8i97pRfm
@sood11 @SiaLindskrog @SWilliams_MD @LDyrskjot @KKBree #SIU2024 #SIU2024NewDelhi @WorldBladderCan
2
20
58
Proud 🥹
2024 49th Annual UNC Lineberger Comprehensive Cancer Center Trainee Day Event. People’s Choice Poster Session Awardee goes to 🔽🔽🔽🔽🔽🔽🔽🔽🔽🔽🔽 Emily Kounlavong ‼️ 📣📣🥳🥳Congratulations Emily 🥳📣📣 @UNC @WilliamKimMD @UNCPathology
0
3
22
This year, we honor Tar Heel legend Eric Montross by swimming to fight cancer. Coach Mack Brown is inviting you to join us at UNC’s Koury Natatorium on Sept 28th. Help us beat last year’s $135,000 raised for UNC Lineberger Cancer Center. Your support makes a big difference!
0
10
113
Huge congrats to @apolo_andrea @sonpavde @DrRosenbergMSK @WilliamKimMD @bergsa83 & the @ALLIANCE_org team on a terrific @myESMO presentation & a concomitant @NEJM paper! A very exciting #ESMO24 indeed!
0
32
85
I am proud that Bladder Cancer @BladderCaJrnl is in its 10th year of publication and it is now fully indexed in Pubmed! The journal is also Open Access making its cutting-edge articles on #bladdercancer freely available. @PubMedOnline
0
6
21
New insights into the biology of kidney cancer, including those informed by scientific discoveries that earned a Nobel Prize, have led to advances in treatment and increased survival rates, according to a review by UNC Lineberger’s @WilliamKimMD, and Tracy L. Rose, MD, MPH.
0
6
10
1
7
48
Check out our correlative analysis of the LCCC1520 clinical trial of neoadjuvant chemo-immunotherapy for muscle-invasive #bladdercancer, now published in @NatureComms. Special thanks to @pirl_unc, the Kim Lab, and all members of the project team! https://t.co/biuYZAYoxU
1
2
8
Great job by @wolfbeckabir leading a fun and productive collaboration! @NatureComms @BenjaminGVincen @WilliamKimMD @MattMilowsky @UNC_Lineberger @UNC_Micro_Imm
https://t.co/C1AMJStIDl
0
3
5
https://t.co/v0NI3VM5F9 Delighted to share our recent publication @jclinicalinvest on the new function of VHL on regulating m6A signaling and mRNA stability in ccRCC tumorigenesis. 1/n
11
12
84
Join @BladdercancerUS and @CDMRP to talk about #researchfunding opportunities 4.17.24 noon(ET)! Tell colleagues too @FaltasLab @PGrivasMDPhD @MaxKates @UroDocAsh @m_e_nielsen @RichMatulewicz @sonpavde @MattMilowsky @WilliamKimMD @SWilliams_MD ...
Attention #bladdercancer researchers! BCAN is hosting a webinar about available funding opportunities for medical research through the Congressionally Directed Medical Research Programs (CDMRP) for 2024. April 17th at 12:00 pm ET. Register here: https://t.co/CwTJwQ4j7U
0
11
13
Medicare couldn’t cover Wegovy for weight loss. But now that it’s also a heart drug, the door is open
statnews.com
Medicare has been forbidden from covering obesity drugs like Wegovy. But now that the drug's cardiovascular benefits can also be touted, there may be an opening.
3
31
70
🎉🔬 The 10th episode is out. ➡️ Checkout for summary of all episodes🧪🔬‼️ https://t.co/mg1I50we47 After #divergent #histology in #urothelial #cancer we will now dive into specific variant urothelial/urothelial subtype histologies! ➡️ General overview on #variant
🌶️🌡️Summary of my uropathology for urologists and oncologists series! 👉check it out! and retweet if you like! @urotoday @OncoAlert @Uroweb @EAUYAUrology @EAU_YAUroTech @EauPatient @niklas_kluemper @onkowissen
https://t.co/jC1aEhztgI
1
4
6
GU Research Digest for the week of February 3 - 9: a selection of publications about GU cancers in high-impact journals. Search the PMIDs on https://t.co/F03S8cX7Rn to read!
0
8
9
Happy Friday! Happy Chinese New Year! Happy to share that our final version of our paper @ModernPathology is now available online at the following link: https://t.co/P4mLeGJ1bo Congrats to Dr. Posada, our former @BrownPathology fellow, and our spectacular international team
3
14
45